ClaimsFiler, a FREE shareholder information service, reminds investors that they have only until May 28, 2018 to file lead plaintiff applications in a securities class action lawsuit against Solid Biosciences Inc. (NasdaqGS: SLDB). Investor losses must relate to purchases of the Company’s shares between January 25, 2018, and March 14, 2018 or in its January 25, 2018 initial public offering. This action is pending in the United States District Court for the District of Massachusetts.

Get Help

Solid Biosciences investors should visit us at https://www.claimsfiler.com/cases/view-solid-biosciences-inc-securities-litigation or call to speak to our claim center toll-free at (844) 367-9658.

About the Lawsuit

On March 14, 2018, the Company disclosed a clinical hold placed on the trial of its lead drug candidate, SGT-001, by the U.S. Food and Drug Administration relating to the occurrence of adverse events. On this news, the price of Solid Biosciences’ shares plummeted over 60% to $9.32/share on March 15, 2018.

About ClaimsFiler

ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. ClaimsFiler’s team of experts monitor the securities class action landscape and cull information from a variety of sources to ensure comprehensive coverage across a broad range of financial instruments.

To learn more about ClaimsFiler, visit www.claimsfiler.com.

ClaimsFilerJerry Gallo, 844-367-9658https://www.claimsfiler.com

Solid Biosciences (NASDAQ:SLDB)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Solid Biosciences Charts.
Solid Biosciences (NASDAQ:SLDB)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Solid Biosciences Charts.